Delivery Order SPE2DB20D3303-SPE2DB24FA1PJ

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,107.53 firm fixed-price contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order for pharmaceutical products awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,402.56, is for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML and has a period of performance through February 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.74, is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.26 firm fixed-price contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,391.70 firm-fixed-price contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical supply product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,833.77, is for the delivery of the pharmaceutical product Zepbound 5 mg/0.5 ml pen. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,766.78 firm fixed-price contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,233.76, is for the supply of the medication "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a period of performance through November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) with a ceiling value of $1,143.87. The award is for the supply of a specific pharmaceutical product, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of February 3, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,481.93, is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price type and has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1PJ
    Delivery Order

This is a delivery order for pharmaceutical products awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,774.32 contract is for the supply of the medication ZEPBOUND 15 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price contract with a completion date of July 31, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support military healthcare worldwide. The company also has an IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024 for similar medical products and prescription drugs. These IDCs enable the government to efficiently procure essential pharmaceutical and medical supplies from AmerisourceBergen for federal healthcare programs. This specific delivery order does not have a set-aside designation.

Generated 10/29/24, 9:21 AM